ALS (amyotrophic lateral sclerosis) Clinical Trials
Recruiting als (amyotrophic lateral sclerosis) studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat als (amyotrophic lateral sclerosis). Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting als (amyotrophic lateral sclerosis) studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting als (amyotrophic lateral sclerosis) trials
FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS
Evaluation of the Impact of Virtual Park on Training Motivation in Adult Patients
Auto-calibrating System for Upper Limb Disability Assessment, Neurological and Occupational Rehabilitation
iBCI Optimization for Veterans With Paralysis
Therapeutic Approach of Repeated Transient Blood-brain Barrier Opening in Amyotrophic Lateral Sclerosis.
Alter-Ego as an Assistive Robotic Device.
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis
Digital Speech Markers for Monitoring ALS in Spanish Speakers
Research of Traditional Chinese Medicine Oral Preparation of C. Cicadae in the Treatment of ALS Patients With Elevated Plasma Sphingolipids
A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis
A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients
Metagenomic Characterization of the Intestinal Microbiota in ALS Patients and Association With Clinical Phenotypes
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Personalized Antisense Oligonucleotide Therapy for A Single Patient With CHCHD10 ALS (nL18576)
Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Efficacy and Safety of Tazbentetol in ALS Participants
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
A Physiotherapy Intervention Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)
Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis
Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)
Assessing Perceptual Effects of Interactive Tasks
VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
Polish Version Dyspnea in Amyotrophic Lateral Sclerosis
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis
Needs of ALS Patients With C9orf72 Mutation and Their Caregivers
Identifying Biomarkers in ALS Patients Using Neuronal Derived Extracellular Vesicles
Electrophysiology and Ultrasound of Respiratory Muscles and Respective Nerves to Predict Respiratory Insufficiency in ALS
Modeling Amyotrophic Lateral Sclerosis With Fibroblasts
Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis
Video-Based Proprioceptive Exercise Program in ALS
Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth
Evaluation of the Early Use of the Pressure Relaxer in the Respiratory Impairment of Patients With Amyotrophic Lateral Sclerosis: Multicenter Randomized Controlled Study.
MRG-001 in Patients With Amyotrophic Lateral Sclerosis
hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases
Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)
A Study of Ranolazine in ALS
High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project
LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS
Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
Research on Wireless Brain Implant System for General Control of External Devices
Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
EIM Via the Myolex mScan as an ALS Biomarker
An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy
Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation
Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS
RAPA-501 Therapy for ALS
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation
Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS
Tofacitinib in Patients With Amyotrophic Lateral Sclerosis
Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
ALS (amyotrophic lateral sclerosis) clinical trials — common questions
Are als (amyotrophic lateral sclerosis) clinical trials free to join?
Yes. Participating in a als (amyotrophic lateral sclerosis) clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a als (amyotrophic lateral sclerosis) clinical trial?
Each als (amyotrophic lateral sclerosis) study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a als (amyotrophic lateral sclerosis) trial near me?
Use the location controls above. We'll show recruiting als (amyotrophic lateral sclerosis) trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many als (amyotrophic lateral sclerosis) trials are recruiting right now?
We're currently tracking roughly 56 recruiting als (amyotrophic lateral sclerosis) trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.